ROCHESTER, Minn. Decreasing testosterone boosts immunity because testosterone helps control T-lymphocytes, the attack cells of the immune system, according to Mayo Clinic-led research in laboratory animals. The findings appear in the Nov. 15 edition of the Journal of Immunology.
Collaborators include scientists from Roswell Park Cancer Institute, Buffalo, N.Y.; the Tumor Immunity and Tolerance section of the Laboratory of Molecular Immunoregulation, National Cancer Institute; and Howard Hughes Medical Institute/Memorial Sloan-Kettering Cancer Center.
"What we are showing is that testosterone seems to impede immunity," says Eugene Kwon, MD, the Mayo Clinic urologist and immunology researcher who led the research team. "However, when testosterone is withdrawn, you get an increased host immune response indicated by the rising numbers of immune cells that are available to participate."
T-lymphocytes are cells that are vital to controlling the body's immune response. "T cells," as they are usually called by scientists, are white blood cells that can fight against tumor cells and infection. Alternatively, T cells can help other immune cells known as "B cells" make antibodies to defend the body against certain bacterial and fungal infections, and possibly against cancer. The research findings may have broad potential applications to public health. For example, knowing that testosterone levels affect T-cell response may help:
* explain why women are more prone than men to develop "autoimmune disease."
* speed the development of drugs that bolster the immune system to treat such immune-deficiency diseases as AIDS.
* improve vaccines.
* decrease the time needed to reconstitute the immune system after bone marrow transplantation.
* protect cancer patients who are receiving immunotherapy treatments or who are vulnerable to infection as a result of chemotherapy.
Significance of the Research
Researchers and physicians have known for years that there is a difference in immunity between men and women -- but they have not known why. The researchers discovered one possible mechanism driving the difference: The presence of testosterone slows or weakens the response of T-lymphocytes. Delving further to discover the mechanism behind this response, the research team found that without testosterone, the T-lymphocytes "turn-on" more quickly.
It also is possible that other sex hormones play a similar role because testosterone is just one of the hormones known as androgens.
"Females are typically more predisposed to the phenomenon of autoimmunity," says Kwon. "And of course, what's interesting about this is that females don't have significant levels of testosterone. Men, on the other hand, may have relatively blunted immune responses and have high levels of testosterone. So these results of our experiment are really very promising for unraveling this gender difference in the immune system." He emphasizes that further research is needed to validate these findings before they can be used in human patients in the clinic.
Background Biology
Kwon frequently cares for patients with prostate cancer. The current experiment grew out of his experience in the clinic. One of the more common forms of treatment for prostate cancer suppresses the patient's testosterone levels to increase the patient's immune attack against cancer. To test the role of testosterone on the immune system in the laboratory, the researchers removed testosterone from male mice.
"They suddenly started growing large numbers of new immune cells," Kwon says. "We also demonstrated that if you take a male mouse and treat it with chemotherapy you can prompt the mouse to recover its immune system much more quickly simply by removing androgen.
When testosterone is removed, the immune cells come back strong and aggressive, ready to attack. Says Kwon, "They become twitchy, very reactive, and in this state they can, in fact, mediate a strong immune response -- which, as physicians, is just what we want."
Collaborators and Support
In addition to Kwon, Mayo Clinic research team members include Anja C. Roden, MD, Samuel D. Tri, Maria Mercader, PhD, Susan M. Kuntz, Haidong Dong, MD, PhD, David J. McKean, PhD, Esteban Celis, MD, and Bradley C. Leibovich, MD. Collaborators from other institutions are: Michael T. Moser, Roswell Park Cancer Institute; Arthur A. Hurwitz, principal investigator, Tumor Immunity and Tolerance Section, Laboratory of Molecular Immunoregulation, National Cancer Institute; and James P. Allison, chairman, Immunology Program, David H. Koch, chair in immunologic studies, attending immunologist, department of medicine, investigator, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center. The work was supported by a National Institutes of Health National Cancer Institute grant; a U.S. Department of Defense grant; and the Mayo Foundation.
Source: Mayo Clinic
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.